Shuling Guo - Concepedia

Author

Shuling Guo

Ionis Pharmaceuticals (United States)ORCID

Also Known As

Guo Shuling, Guo, Shuling, S. Guo, SHULING GUO, Shao-Peng Guo, Shuling Guo, Shuling Guo (774846)

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Ionis Pharmaceuticals (United States)University of Michigan Universidad de Navarra University of California San Diego Michigan Center for Translational Pathology

About

Shuling Guo is an author at Ionis Pharmaceuticals (United States) specializing in medicine, non-coding rna, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.2K
2	Engineering	2	2	135
3	Allergy	2	2	206
4	Health Sciences	1	1	34
5	Natural Sciences	1	1	42

Shuling Guo

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary<i>N</i>-acetyl galactosamine improves potency 10-fold in mice Thazha P. Prakash, Mark J. Graham, Jinghua Yu, Nucleic Acids Research	2014	579
PintlincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2 Oskar Marín-Béjar, Francesco P. Marchese, Alejandro Athie, Genome biology	2013	266
The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element Oskar Marín-Béjar, Aina Maria Mas, Jovanna González, Genome biology	2017	259
Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA Yasuyuki Hosono, Yashar S. Niknafs, John R. Prensner, Cell Tumor BiologyOncogenic RolePathologyLong Non-coding RnaSmall Rna	2017	250
Analysis of the androgen receptor–regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression Yajia Zhang, Sethuramasundaram Pitchiaya, Marcin Cieślik, Nature Genetics Transcriptional RegulationMedicineProstate Cancer ProgressionProstatic DiseaseSystems Biology	2018	237
An inducible long noncoding RNA amplifies DNA damage signaling Adam M. Schmitt, Julia T. Garcia, Tiffany Hung, Nature Genetics ChromatinTranscriptional RegulationDna DamageRna BiologyMolecular Biology	2016	233
Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature Yolanda Sánchez, Víctor Segura, Oskar Marín-Béjar, Nature Communications	2014	194
Peripheral Androgen Receptor Gene Suppression Rescues Disease in Mouse Models of Spinal and Bulbar Muscular Atrophy Andrew P. Lieberman, Zhigang Yu, Sue Murray, Cell Reports	2014	173
Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy Elizabeth J. Ackermann, Shuling Guo, Sheri Booten, Amyloid	2012	132
Characterization of Target mRNA Reduction Through <i>In Situ</i> RNA Hybridization in Multiple Organ Systems Following Systemic Antisense Treatment in Animals Gene Hung, Xiaokun Xiao, Raechel Peralta, Nucleic Acid Therapeutics ImmunologyAntisense Oligonucleotide DrugsAntisense TherapyNovel TherapyTarget Mrna Reduction	2013	126

Page 1